Creates the expanded pharmaceutical insurance coverage panel, to be responsible for expanding pharmaceutical insurance coverage.
Summary
Bill A01040 proposes the establishment of an 'expanded pharmaceutical insurance coverage panel' within the executive department of New York. This panel will consist of various department heads and will be co-chaired by the director of the office for the aging and the commissioner of health. The panel's primary responsibilities include promulgating regulations, determining cost-sharing responsibilities for eligible participants, entering contracts, recommending program improvements, and developing outreach programs to inform eligible applicants about their benefits.
Impact
The bill amends the elder law by adding a new section that introduces a structured approach to expanding pharmaceutical insurance coverage for eligible New York residents, particularly seniors. It aims to enhance the efficiency and effectiveness of the existing pharmaceutical coverage programs and ensure that more residents are aware of and can access these benefits. This could lead to increased enrollment in pharmaceutical assistance programs and potentially lower out-of-pocket costs for eligible participants.
Sentiment
The sentiment surrounding Bill A01040 appears to be generally supportive, as it addresses the critical issue of pharmaceutical coverage for the aging population. However, without specific voting history or committee discussion transcripts, it is difficult to gauge the full extent of support or opposition from various stakeholders.
Contention
Notable points of contention may arise regarding the composition of the advisory committee, particularly the representation of consumers versus pharmaceutical industry representatives. There may be concerns from consumer advocates about ensuring that the interests of seniors and low-income individuals are prioritized over those of pharmaceutical manufacturers and wholesalers.
Same As
Relates to improving and expanding the pharmaceutical insurance coverage program for certain medicare enrollees; creates the expanded pharmaceutical insurance coverage panel, to be responsible for expanding pharmaceutical insurance coverage.
Relates to improving and expanding the pharmaceutical insurance coverage program for certain medicare enrollees; creates the expanded pharmaceutical insurance coverage panel, to be responsible for expanding pharmaceutical insurance coverage.